Tenax Therapeutics Inc. (TENX)
$11.98
$0.08
(0.67%)
As on 15-May-2026 16:00EDT
Market cap
$318 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
3.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.5 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0.1
-
Debt to Equity
0
-
Book Value
$2.3
-
EPS
$-1.4
-
Face value
--
-
Shares outstanding
26,525,159
10 Years Aggregate
CFO
$-98.12 Mln
EBITDA
$-135.24 Mln
Net Profit
$-162.87 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Tenax Therapeutics (TENX)
| -1.7 | -18.9 | -5.3 | 110.9 | -25.4 | -67.5 | -58.8 |
|
BSE Sensex
| -11.1 | -2.1 | -8.9 | -7.5 | 6.6 | 9.1 | 11.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Tenax Therapeutics (TENX)
| 96.9 | -71.6 | -87.7 | -89.3 | -44.1 | 31.9 | 16.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Tenax Therapeutics (TENX)
|
12.0 | 317.8 | 0.0 | -57.9 | -- | -54.9 | -- | 3.1 |
| 76.7 | 10,799.5 | 622.0 | -300.9 | -30.1 | -62 | -- | 16.7 | |
| 240.5 | 14,858.0 | 867.5 | 506.6 | -2.8 | -- | 27.1 | 25.7 | |
| 75.9 | 10,298.2 | 105.8 | -829.6 | -715.0 | -- | -- | 60.3 | |
| 50.1 | 12,600.4 | 2,375.5 | 833.4 | 40.8 | 40.7 | 16.6 | 6.3 | |
| 94.9 | 12,586.4 | 1,080.2 | -433.2 | -39.8 | -- | -- | 55.7 | |
| 306.3 | 9,097.8 | 417.3 | 225.0 | 42.8 | 18.6 | 41.3 | 7.1 | |
| 523.7 | 12,074.0 | 1,132.5 | -309.4 | -25.5 | -52.9 | -- | 21.6 | |
| 415.3 | 11,860.0 | 2,678.3 | 460.4 | 21.1 | 103.2 | 26.1 | 20.2 | |
| 342.6 | 9,550.7 | 0.0 | -326.5 | -- | -37.2 | -- | 6.5 |
Shareholding Pattern
View DetailsAbout Tenax Therapeutics (TENX)
Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the... treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Chapel Hill, North Carolina. Read more
-
CEO, President & Director
Mr. Christopher T. Giordano
-
CEO, President & Director
Mr. Christopher T. Giordano
-
Headquarters
Chapel Hill, NC
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Tenax Therapeutics (TENX)
What is the current share price of Tenax Therapeutics Inc (TENX) Today?
The share price of Tenax Therapeutics Inc (TENX) is $11.98 (NASDAQ) as of 15-May-2026 16:00 EDT. Tenax Therapeutics Inc (TENX) has given a return of -25.35% in the last 3 years.
What is the current PB & PE ratio of Tenax Therapeutics Inc (TENX)?
Since, TTM earnings of Tenax Therapeutics Inc (TENX) is negative, P/E ratio is not available.
The P/B ratio of Tenax Therapeutics Inc (TENX) is 3.09 times as on 15-May-2026, a 31 discount to its peers’ median range of 4.49 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-9.09
|
4.92
|
|
2024
|
-5.37
|
1.03
|
|
2023
|
-0.01
|
0.01
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Tenax Therapeutics Inc (TENX)?
The 52-week high and low of Tenax Therapeutics Inc (TENX) are Rs 18.29 and Rs 5.34 as of 17-May-2026.
What is the market cap of Tenax Therapeutics Inc (TENX)?
Tenax Therapeutics Inc (TENX) has a market capitalisation of $ 318 Mln as on 15-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Tenax Therapeutics Inc (TENX)?
Before investing in Tenax Therapeutics Inc (TENX), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.